Skip to main content
. 2014 May 3;6:79–86. doi: 10.2147/CPAA.S61462

Figure 1.

Figure 1

Changes in blood pressure (A) and eGFR (B) of a total of 107 patients from the baseline compared with 12 months’ irbesartan treatment.

Notes: *P<0.05, **P<0.01, ***P<0.001 versus the baseline.

Abbreviations: DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure.